Literature DB >> 18762122

Nonoperative treatment of Dupuytren's disease.

Ghazi M Rayan1.   

Abstract

Many approaches to nonoperative treatment of Dupuytren's disease have been tried since the disease was originally described in 1831, and most have been abandoned. Nonetheless, the appeal for nonoperative methods persists, in pursuit of lower morbidity and lesser complications than may be encountered with open surgical treatment. A number of nonoperative treatment modalities are in current use for Dupuytren's disease, despite lack of high-level clinical studies supporting these methods. Some of these can be utilized as an adjunct to surgical treatment rather than a replacement for it. The most commonly used nonoperative treatment methods are briefly reviewed.

Mesh:

Year:  2008        PMID: 18762122     DOI: 10.1016/j.jhsa.2008.05.027

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  12 in total

1.  Molecular mechanisms and treatment strategies for Dupuytren's disease.

Authors:  David B O'Gorman; Linda Vi; Bing Siang Gan
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

2.  Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren's contracture.

Authors:  Nash H Naam
Journal:  Hand (N Y)       Date:  2013-12

3.  The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease.

Authors:  Alexis Thomas; Ardeshir Bayat
Journal:  Ther Clin Risk Manag       Date:  2010-11-04       Impact factor: 2.423

4.  Prevalence, incidence, and treatments of Dupuytren's disease in the United States: results from a population-based study.

Authors:  Dana Britt Dibenedetti; Dat Nguyen; Laurie Zografos; Ryan Ziemiecki; Xiaolei Zhou
Journal:  Hand (N Y)       Date:  2010-11-16

5.  Dupuytren's Disease: Review of the Current Literature.

Authors:  Morsi Khashan; Peter J Smitham; Wasim S Khan; Nicholas J Goddard
Journal:  Open Orthop J       Date:  2011-07-28

6.  Use of resources and costs associated with the treatment of Dupuytren's contracture at an orthopedics and traumatology surgery department in Denia (Spain): collagenase clostridium hystolyticum versus subtotal fasciectomy.

Authors:  Rafael Sanjuan Cerveró; Nuria Franco Ferrando; Jaime Poquet Jornet
Journal:  BMC Musculoskelet Disord       Date:  2013-10-14       Impact factor: 2.362

7.  Collagenase Dupuytren Contracture: Achieving Single Treatment Success with a Hand Therapist-Based Protocol.

Authors:  Menyoli M Malafa; Craig Lehrman; Jerry W Criley; Bardia Amirlak
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-02-26

8.  Embryonic Stem Cell-Like Population in Dupuytren's Disease Expresses Components of the Renin-Angiotensin System.

Authors:  Nicholas On; Sabrina P Koh; Helen D Brasch; Jonathan C Dunne; James R Armstrong; Swee T Tan; Tinte Itinteang
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-07-24

9.  Collagenase Management of Multicord Dupuytren's Disease under Intravenous Sedation: A Prospective Cohort Study.

Authors:  Jeremy Wiseman; Kevin Tree; Pedro Guio-Aguilar; George Pratt; Danielle Nizzaro; Michael Leung; James Leong
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-02-20

Review 10.  Systematic review of non-surgical treatments for early dupuytren's disease.

Authors:  Catherine Ball; David Izadi; Liaquat Suleman Verjee; James Chan; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2016-08-15       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.